跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ABIRATERONA QILU 250 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ABIRATERONA QILU 250 MG COMPRIMIDOS EFG
Approved
STANDARD
ABIRATERONA QILU 250 MG COMPRIMIDOS EFG
Qilu Pharma Spain S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 10, 2022
Approval ID
eef399802b29a49f
Company
Qilu Pharma Spain S.L.
Type
Standard
Approval Details
Approval Id
eef399802b29a49f
Drug Cima Aemps Name
ABIRATERONA QILU 250 MG COMPRIMIDOS EFG
Register Number
88176
Holder Company Name
Qilu Pharma Spain S.L.
Marketing Company Name
Qilu Pharma Spain S.L.
Holder Company Detail Path
/organization/qilu-pharma-spain-sl
Marketing Company Detail Path
/organization/qilu-pharma-spain-sl
Authorization Date
2022-10-10
Dosage Form
COMPRIMIDO
Dose
250 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Qilu Pharma Spain S.L.
Company Detail Path
/organization/qilu-pharma-spain-sl
Company Information
Pharmaceutical Company Name
QILU PHARMA SPAIN SL.
Country Name
Spain
City Name
madrid,madrid,country_es
Address
PASEO CASTELLANA, 40 - PISO 8
Active Ingredients
ABIRATERONA ACETATO
250 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 10, 2022
Approval ID
eef399802b29a49f
Type
Standard
Back to CIMA-AEMPS Approvals